Portola Pharmaceuticals, Inc.
270 E Grand Ave, Ste 22
South San Francisco, CA 94080-4811
Biotech and Pharmaceutical
Portola is dedicated to discovering, developing and commercializing novel therapeutics for the prevention and treatment of cardiovascular disease. The company believes that its integrated approach applied to its comprehensive understanding of platelet physiology and vascular thrombosis will result in new therapeutics where current therapies are inadequate. Portola is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular disease and inflammation. Portola’s two most advanced product candidates are in Phase 2 clinical trials. The company is located in South San Francisco in Congresswoman Jackie Speier’s district, Senator Leland Yee’s district and Assemblymember Jerry Hill district. For more information on Portola, visit: www.portola.com.